Clavis Pharma ASA of Norway, which has two cancer drugs in clinical development, has appointed Geir Christian Melen as chief executive officer, replacing Tom Pike, who has been nominated as executive chairman of the board.
Mr Christian Melen is currently chief financial officer of Algeta ASA and will assume his new job once he is relieved of his duties or has served out his six-month notice period.
Sources:
Clavis press release, 17 September 2007
Algeta press release, 17 September 2007
Copyright 2007 Evernow Publishing